Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Elisaf · SciRah

Researcher profile · Semantic Scholar

M. Elisaf

Share profile

M. Elisaf — researcher profile on SciRah

h-index: 79
Works: 864
Citations: 26K

Most-cited papers

Hyponatremia in the elderly: challenges and solutions
T. Filippatos, A. Makri, M. Elisaf, G. Liamis
2017Clinical Interventions in Aging164 citations Open access
Semantic Scholar
SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses
T. Filippatos, Angelos Liontos, Ioanna Papakitsou, M. Elisaf
2019Postgraduate medicine90 citations
Semantic Scholar
SGLT2 inhibitors: are they safe?
S. Filippas-Ntekouan, T. Filippatos, M. Elisaf
2018Postgraduate medicine64 citations
Semantic Scholar
Lipid testing in infectious diseases: possible role in diagnosis and prognosis
S. Filippas-Ntekouan, Evaggelos Liberopoulos, M. Elisaf
2017Infection64 citations
Semantic Scholar
SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipids
S. Filippas-Ntekouan, V. Tsimihodimos, T. Filippatos, T. Dimitriou +1 more
2018Expert Opinion on Drug Metabolism & Toxicology62 citations
Semantic Scholar
Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe
J. Ferrières, G. D. de Ferrari, M. Hermans, M. Elisaf +9 more
2018European Journal of Preventive Cardiology62 citations Open access
Semantic Scholar
Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
E. Christopoulou, M. Elisaf, T. Filippatos
2019Disease Markers51 citations Open access
Semantic Scholar
SGLT1 inhibition: Pros and cons
V. Tsimihodimos, S. Filippas-Ntekouan, M. Elisaf
2018European Journal of Pharmacology49 citations
Semantic Scholar
Drug-Induced Hypophosphatemia: Current Insights
E. Megapanou, M. Florentin, H. Milionis, M. Elisaf +1 more
2019Drug Safety48 citations
Semantic Scholar
Hyponatremia in Acute Stroke Patients: Pathophysiology, Clinical Significance, and Management Options
G. Liamis, F. Barkas, E. Megapanou, E. Christopoulou +5 more
2019European Neurology48 citations Open access
Semantic Scholar
Uric acid and incident chronic kidney disease in dyslipidemic individuals
Fotis Barkas, M. Elisaf, Evaggelos Liberopoulos, R. Kalaitzidis +1 more
2018Current Medical Research and Opinion43 citations
Semantic Scholar
Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables
T. Filippatos, A. Kei, C. Rizos, M. Elisaf
2018Journal of Cardiovascular Pharmacology and Therapeutics42 citations Open access
Semantic Scholar
Treatment of Hypertension in Chronic Kidney Disease
R. Kalaitzidis, M. Elisaf
2018Current Hypertension Reports40 citations
Semantic Scholar
Hyponatremia-Inducing Drugs.
G. Liamis, E. Megapanou, M. Elisaf, H. Milionis
2019Frontiers of Hormone Research39 citations
Semantic Scholar
Protection against stroke with glucagon‐like peptide 1 receptor agonists: a systematic review and meta‐analysis
F. Barkas, M. Elisaf, H. Milionis
2019European Journal of Neurology39 citations
Semantic Scholar
Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity
R. Kalaitzidis, A. Duni, Georgios Liapis, O. Balafa +3 more
2017International Urology and Nephrology35 citations
Semantic Scholar
Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
C. Rizos, M. Elisaf, I. Skoumas, K. Tziomalos +12 more
2018Atherosclerosis34 citations
Semantic Scholar
Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?
E. Rizos, M. Elisaf
2017Current Cardiology Reports30 citations
Semantic Scholar
Sitosterolemia: A multifaceted metabolic disorder with important clinical consequences.
Eleftheria Tzavella, E. Hatzimichael, C. Kostara, E. Bairaktari +2 more
2017Journal of Clinical Lipidology30 citations
Semantic Scholar
Pharmacological management of diabetic dyslipidemia
T. Filippatos, M. Florentin, M. Georgoula, M. Elisaf
2017Expert Review of Clinical Pharmacology30 citations
Semantic Scholar
PCSK9 inhibitors in clinical practice: novel directions and new experiences.
L. Rallidis, I. Skoumas, E. Liberopoulos, C. Vlachopoulos +7 more
2019Hellenic Journal of Cardiology27 citations Open access
Semantic Scholar
Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023.
N. Katsiki, T. Filippatos, C. Vlachopoulos, D. Panagiotakos +20 more
2024Atherosclerosis Plus25 citations Open access
Semantic Scholar
Uric acid and cardiovascular risk: What genes can say
A. Kei, Freideriki Koutsouka, A. Makri, M. Elisaf
2018International journal of clinical practice24 citations Open access
Semantic Scholar
Arterial damage and cognitive decline in chronic kidney disease patients
D. Karasavvidou, P. Boutouyrie, R. Kalaitzidis, H. Kettab +6 more
2018The Journal of Clinical Hypertension23 citations Open access
Semantic Scholar
Cardioprotective Properties Of Hdl: Structural And Functional Considerations.
E. Pappa, M. Elisaf, C. Kostara, E. Bairaktari +1 more
2019Current Medicinal Chemistry22 citations
Semantic Scholar
Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes
C. Kostara, E. Ferrannini, E. Bairaktari, Athanasios I. Papathanasiou +2 more
2020International Journal of Molecular Sciences21 citations Open access
Semantic Scholar
Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications
A. Tzamaloukas, Z. Khitan, R. Glew, M. Roumelioti +11 more
2019Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease21 citations Open access
Semantic Scholar
Pleiotropic effects of proprotein convertase subtilisin/kexin type 9 inhibitors?
T. Filippatos, E. Christopoulou, M. Elisaf
2018Current Opinion in Lipidology21 citations
Semantic Scholar
Effects of incretin‐based therapies on renal function
V. Tsimihodimos, M. Elisaf
2018European Journal of Pharmacology20 citations
Semantic Scholar
Non-hemorrhage-related adverse effects of rivaroxaban
E. Christopoulou, T. Filippatos, M. Elisaf
2017Archives of medical sciences. Atherosclerotic diseases20 citations Open access
Semantic Scholar
Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity.
F. Barkas, M. Elisaf, E. Liberopoulos, G. Liamis +2 more
2019Journal of Cardiology19 citations Open access
Semantic Scholar
Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes
Ioanna Papakitsou, G. Vougiouklakis, M. Elisaf, T. Filippatos
2019Clinical Pharmacology : Advances and Applications19 citations Open access
Semantic Scholar
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
T. Filippatos, A. Kei, M. Elisaf
2017Diseases19 citations Open access
Semantic Scholar
Apolipoprotein CIII and diabetes. Is there a link?
E. Christopoulou, V. Tsimihodimos, T. Filippatos, M. Elisaf
2019Diabetes/Metabolism Research Reviews17 citations
Semantic Scholar
Emerging Fixed-Dose Combination Treatments for Hyperlipidemia
E. Pappa, C. Rizos, T. Filippatos, M. Elisaf
2019Journal of Cardiovascular Pharmacology and Therapeutics16 citations
Semantic Scholar
Incretins and Lipid Metabolism.
V. Tsimihodimos, M. Elisaf
2017Current Medicinal Chemistry16 citations
Semantic Scholar
Recommendations for lipid modification in patients with ischemic stroke or transient ischemic attack: A clinical guide by the Hellenic Stroke Organization and the Hellenic Atherosclerosis Society
D. Sagris, Georgios Ntaios, G. Georgiopoulos, N. Kakaletsis +17 more
2020International Journal of Stroke15 citations
Semantic Scholar
Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)
J. Ferrières, D. Lautsch, A. Gitt, G. D. de Ferrari +8 more
2018Diabetes, obesity and metabolism15 citations Open access
Semantic Scholar
Antidiabetic Drugs and the Kidney.
V. Tsimihodimos, Nikolaos Karanatsis, E. Tzavela, M. Elisaf
2017Current pharmaceutical design15 citations
Semantic Scholar
Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.
J. Ferrières, D. Lautsch, B. Ambegaonkar, G. D. de Ferrari +11 more
2018International Journal of Cardiology14 citations Open access
Semantic Scholar
Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome
K. Archontogeorgis, N. Papanas, E. Rizos, E. Nena +7 more
2019Medicina11 citations Open access
Semantic Scholar
Effect of combined vitamin D administration plus dietary intervention on oxidative stress markers in patients with metabolic syndrome: A pilot randomized study.
S. Makariou, M. Elisaf, A. Challa, C. Tellis +2 more
2019Clinical Nutrition ESPEN11 citations
Semantic Scholar
Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II
E. Liberopoulos, L. Rallidis, F. Spanoudi, E. Xixi +7 more
2018Archives of medical science : AMS11 citations Open access
Semantic Scholar
Metabolically healthy obesity and risk of incident type 2 diabetes in 1077 statin-treated individuals: A six-year retrospective study
F. Barkas, G. Liamis, M. Elisaf, G. Anastasiou +1 more
2020European Journal of Preventive Cardiology10 citations
Semantic Scholar
Pharmacological management of hyponatremia
T. Filippatos, M. Elisaf, G. Liamis
2018Expert Opinion on Pharmacotherapy10 citations
Semantic Scholar
Severe hyperkalemia following blood transfusions: Is there a link?
C. Rizos, H. Milionis, M. Elisaf
2017World Journal of Nephrology10 citations Open access
Semantic Scholar
Evacetrapib and cardiovascular outcomes: reasons for lack of efficacy.
T. Filippatos, M. Elisaf
2017Journal of Thoracic Disease10 citations Open access
Semantic Scholar
Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes
C. Rizos, T. Filippatos, M. Elisaf
2018Expert Opinion on Drug Metabolism & Toxicology8 citations
Semantic Scholar
Hypolipidemic Drugs and Diabetes Mellitus—Mechanisms and Data From Genetic Trials
T. Filippatos, T. Panagiotopoulou, Eleftheria Tzavella, M. Elisaf
2018Journal of Cardiovascular Pharmacology and Therapeutics8 citations
Semantic Scholar
Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries.
M. Florentin, M. Kostapanos, M. Elisaf, E. Liberopoulos
2019Current pharmaceutical design7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Filippatos×17
Invite
T. Filippatos — researcher profile on SciRah
G. Liamis×8
Invite
G. Liamis — researcher profile on SciRah
V. Tsimihodimos×7
Invite
V. Tsimihodimos — researcher profile on SciRah
E. Liberopoulos×7
Invite
E. Liberopoulos — researcher profile on SciRah

E. Christopoulou

×5

Invite

E. Christopoulou — researcher profile on SciRah

Invite

H. Milionis — researcher profile on SciRah

Invite

C. Rizos — researcher profile on SciRah

Invite

M. Horack — researcher profile on SciRah

Invite

P. Brudi — researcher profile on SciRah

Invite

D. Lautsch — researcher profile on SciRah

B. Ambegaonkar×4

Invite

B. Ambegaonkar — researcher profile on SciRah

Invite

A. Gitt — researcher profile on SciRah